VAN VOORHEES SETH
SEC CIK 1284934 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | CFO | 46.3K | $69.4K | — | 3 | 2022-11-25 | 2022-12-16 |
Most active insiders at NRXP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
VAN VOORHEES SETH made no open-market trades at NRXP in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2022-12-19 | 2022-11-25 | NRXP | NRX Pharmaceuticals, Inc. | VAN VOORHEES SETH | CFO | P - Purchase | $1.11 | +16.3K | 16.3K | New | +$18.2K |
| 2022-12-19 | 2022-12-16 | NRXP | NRX Pharmaceuticals, Inc. | VAN VOORHEES SETH | CFO | P - Purchase | $1.10 | +30.0K | 46.3K | +184% | +$33.0K | |
| MI | 2022-11-28 | 2022-11-25 | NRXP | NRX Pharmaceuticals, Inc. | VAN VOORHEES SETH | CFO | P - Purchase | $1.11 | +16.3K | 8,716 | New | +$18.2K |
Purchase Sale Sale after option exercise All abbreviations